PA8.F Paion AG (XETRA) down 51.61% intraday 24 Feb 2026: what investors should watch
PA8.F stock plunged 51.61% to €0.06 on XETRA intraday trading on 24 Feb 2026, making it one of Germany’s top losers today. Paion AG (PA8.F) traded 12,000 shares versus an average volume of 2,162, signalling abnormal activity in this Healthcare small cap. Investors are reacting to thin liquidity and a wide intraday bid-ask swing after a prior close of €0.124.
Price action: PA8.F stock intraday drop
The core fact is the price: PA8.F stock opened at €0.06 and remained at the day low €0.06, down €0.064 from the previous close of €0.124. Volume spiked to 12,000 shares, a relative volume of 5.55, indicating outsized flows for this listing on XETRA.
This move places PA8.F well below its 50-day average of €0.02185 and above its 200-day average of €0.01452, reflecting extreme short-term volatility in a tiny market-cap stock (market cap €613,498).
Catalysts and PA8.F stock news drivers
There is no single public regulatory announcement in the feed today from Paion AG, but the fall aligns with liquidity shocks common to micro-cap Healthcare names on XETRA. Thin order books can amplify sell pressure when larger sell orders hit the tape.
Investors should watch upcoming events: Paion’s next earnings announcement is scheduled for 02 Apr 2026 and any interim operational update could reprice expectations quickly.
Financials and valuation: PA8.F stock metrics
On trailing metrics, PA8.F shows a negative PE (PE TTM -1.06) and a price-to-sales ratio of 0.01845, reflecting a tiny market cap against reported revenue per share. Net income per share is -0.08116, while gross margin reads 94.10%, indicating product-level profitability but negative net results.
Capital structure metrics are thin: shares outstanding 7,133,700 and enterprise value near €613,498. These figures suggest high sensitivity to cash flows, dilution risk, and event-driven revaluations.
Technical outlook: PA8.F stock indicators
Momentum indicators show downside pressure: RSI 46.83 and CCI -141.47 suggest the stock is near oversold short term. ADX at 47.52 signals a strong trend, currently to the downside.
Bollinger Bands (Upper €0.22, Middle €0.12, Lower €0.02) imply large volatility bands. Traders should expect wide intraday ranges and low liquidity on XETRA for PA8.F stock.
Meyka AI rates PA8.F with a score out of 100 and forecast
Meyka AI rates PA8.F with a score of 62.91 out of 100 (Grade B, suggestion: HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, industry comparison, financial growth, key metrics, forecasts, analyst consensus, and fundamental growth.
Meyka AI’s forecast model projects a monthly target of €0.34 and a quarterly figure of €0.06. Compared to the current price €0.06, the model implies a potential monthly upside of 466.67% to €0.34, but the quarterly projection is neutral versus market. Forecasts are model-based projections and not guarantees.
Final Thoughts
PA8.F stock is trading as an intraday top loser on XETRA at €0.06, down 51.61% on thin volume and wide volatility that routinely affects micro-cap Healthcare listings in Germany. The balance of metrics shows product-level gross margins (94.10%) but negative net income per share (-0.08116), a tiny market cap (€613,498), and meaningful liquidity risk. For risk management we outline two scenario price targets: a cautious bull target at €0.12 (implied upside 100.00%) and a conservative bear scenario at €0.02 (implied downside 66.67%). Meyka AI’s forecast model projects a monthly level of €0.34, which implies upside of 466.67% from the current price, but that projection depends on improved liquidity and positive operational news. Given the grade (B, HOLD) and the stock’s volatility, investors seeking exposure should size positions small, expect rapid repricing around the April earnings date, and monitor order book depth on XETRA. All forecasts are model-based projections and not guarantees. For the latest filings and company updates see Paion’s site and our stock page for live data and alerts source Meyka PA8.F page.
FAQs
Why did PA8.F stock drop so sharply today?
The sharp drop reflects low liquidity on XETRA, a large net sell flow against a thin order book, and short-term risk aversion in micro-cap Healthcare names. Volume jumped to 12,000 versus an average 2,162, amplifying price moves.
What is the Meyka AI forecast for PA8.F stock?
Meyka AI’s forecast model projects a monthly level of €0.34 and a quarterly figure of €0.06. The monthly projection implies an upside of 466.67% from €0.06. Forecasts are model-based projections and not guarantees.
Is PA8.F stock a buy after this decline?
Meyka AI assigns PA8.F a B (HOLD) grade. Given negative net income per share and tiny market cap, the stock is high risk. Consider position sizing, wait for clearer earnings or operational updates, and monitor XETRA liquidity.
When is Paion AG’s next earnings announcement?
Paion AG has an earnings announcement scheduled for 02 Apr 2026. That event is a likely catalyst for renewed volatility in PA8.F stock and should be watched closely for revenue and cash flow updates.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.